23/323 |
Pagers |
23/322 |
NHS Charging of Overseas Visitors |
23/320 |
CACNA1C Gene Change |
23/319 |
Overseas Recruitment of Clinical Staff |
23/318 |
Solar Technology Product |
23/317 |
Ovarian Cancer Treatment |
23/316 |
Histology Services |
23/314 |
Sexual Assaults in Hospitals |
23/313 |
Occupational Health |
23/312 |
NHS E-Rostering Capabilities |
23/310 |
Adverse Events Reporting Rates |
23/308 |
Staff Panic Alarms Purchase |
23/306 |
Intra-vitreal Injections or Implants |
23/304 |
Pharmacy & Multiple Sclerosis |
23/303 |
Use of Postal Services by ESHT |
23/300 |
Biologic Medicines in Dermatology |
23/299 |
Community Trust Service |
23/298 |
Thyroid Medications & Reproductive Medication |
23/297 |
Fibromyalgia |
23/295 |
Usage of Biologic and Biosimilar Products |